The American Academy of Pediatrics plans to review the evidence for irreversible, experimental transgender care for children and may amend its policies on the matter, according to a report from the Wall Street Journal.
Reportedly, the review will include evaluations of care such as puberty blockers and hormone therapy treatment. Children who identify as “transgender” and believe their biological sex does not align with their “gender identity” may undergo this type of care, in addition to irreversible sex reassignment surgery (via the Wall Street Journal):
Read more at Townhall.
Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.
"*" indicates required fields